Media

Media

Advanced Search
  • Jul 21, 2020
    Webcast scheduled for Tuesday, August 4 at 4:30 p.m. Eastern Time

    Akcea Therapeutics, Inc. (NASDAQ:AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., announced today that it will host a live webcast on Tuesday, August 4 at 4:30 p.m. Eastern Time...

  • Jul 20, 2020
    Dr. Christophe Hotermans joins company, with a decade of clinical practice and 12 years of experience in global biotechnology sector

    Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that Christophe Hotermans, M.D., Ph.D., has joined the company as senior vice...

  • Jul 9, 2020
    Dr. William Andrews brings two decades of global industry experience, including more than 13 years in rare diseases and seven product launches

    Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that William Andrews, MD, FACP, has joined the company as chief medical officer...

  • Jun 29, 2020
    Berns brings more than 20 years of experience in life sciences sector

    Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that Tracy Palmer Berns has joined the company as chief compliance officer. In...

  • Jun 17, 2020

    Akcea Therapeutics, Inc. (NASDAQ:AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious and rare diseases,...

Show 5102550100 per page